FierceBiotech 1. Apr. 2026 KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech 25. März 2026 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech 12. März 2026 Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
FierceBiotech 25. Feb. 2026 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
FierceBiotech 28. Jan. 2026 With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
FierceBiotech 21. Jan. 2026 Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
FierceBiotech 15. Jan. 2026 Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
FierceBiotech 25. Nov. 2025 <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk